Literature DB >> 19729054

Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia.

K M Prasad1, M E Talkowski, K V Chowdari, L McClain, R H Yolken, V L Nimgaonkar.   

Abstract

Identification of causative factors for common, chronic disorders is a major focus of current human health science research. These disorders are likely to be caused by multiple etiological agents. Available evidence also suggests that interactions between the risk factors may explain some of their pathogenic effects. While progress in genomics and allied biological research has brought forth powerful analytic techniques, the predicted complexity poses daunting analytic challenges. The search for pathogenesis of schizophrenia shares most of these challenges. We have reviewed the analytic and logistic problems associated with the search for pathogenesis. Evidence for pathogenic interactions is presented for selected diseases and for schizophrenia. We end by suggesting 'recursive analyses' as a potential design to address these challenges. This scheme involves initial focused searches for interactions motivated by available evidence, typically involving identified individual risk factors, such as candidate gene variants. Putative interactions are tested rigorously for replication and for biological plausibility. Support for the interactions from statistical and functional analyses motivates a progressively larger array of interactants that are evaluated recursively. The risk explained by the interactions is assessed concurrently and further elaborate searches may be guided by the results of such analyses. By way of example, we summarize our ongoing analyses of dopaminergic polymorphisms, as well as infectious etiological factors in schizophrenia genesis.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19729054      PMCID: PMC5025031          DOI: 10.1016/j.brainresbull.2009.08.023

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  51 in total

1.  A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes.

Authors:  Heather J Cordell; David G Clayton
Journal:  Am J Hum Genet       Date:  2001-11-21       Impact factor: 11.025

Review 2.  Detecting epistatic interactions contributing to quantitative traits.

Authors:  Robert Culverhouse; Tsvika Klein; William Shannon
Journal:  Genet Epidemiol       Date:  2004-09       Impact factor: 2.135

3.  Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia.

Authors:  Shih-Fen Chen; Chia-Hsiang Chen; Jen-Yeu Chen; Ying-Chieh Wang; I-Ching Lai; Ying-Jay Liou; Ding-Lieh Liao
Journal:  Schizophr Res       Date:  2007-01-16       Impact factor: 4.939

4.  A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction.

Authors:  Digna R Velez; Bill C White; Alison A Motsinger; William S Bush; Marylyn D Ritchie; Scott M Williams; Jason H Moore
Journal:  Genet Epidemiol       Date:  2007-05       Impact factor: 2.135

5.  A novel method to identify gene-gene effects in nuclear families: the MDR-PDT.

Authors:  E R Martin; M D Ritchie; L Hahn; S Kang; J H Moore
Journal:  Genet Epidemiol       Date:  2006-02       Impact factor: 2.135

6.  Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk.

Authors:  K K Nicodemus; S Marenco; A J Batten; R Vakkalanka; M F Egan; R E Straub; D R Weinberger
Journal:  Mol Psychiatry       Date:  2008-01-15       Impact factor: 15.992

7.  Gene-centric genomewide association study via entropy.

Authors:  Yuehua Cui; Guolian Kang; Kelian Sun; Minping Qian; Roberto Romero; Wenjiang Fu
Journal:  Genetics       Date:  2008-05-05       Impact factor: 4.562

8.  Segregation analysis of schizophrenia under a mixed genetic model.

Authors:  C L Carter; C S Chung
Journal:  Hum Hered       Date:  1980       Impact factor: 0.444

9.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  7 in total

Review 1.  Genetic association studies of antioxidant pathway genes and schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil N Bamne; Vishwajit L Nimgaonkar
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

2.  Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Appl Clin Genet       Date:  2012-02-20

3.  Psychopharmacology of schizophrenia: The Future Looks Bleak.

Authors:  Chittaranjan Andrade; Rajiv Radhakrishnan; Praveen P Fernandes
Journal:  Mens Sana Monogr       Date:  2012-01

Review 4.  Gene x environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging.

Authors:  Pierre Alexis Geoffroy; Bruno Etain; Josselin Houenou
Journal:  Front Psychiatry       Date:  2013-10-14       Impact factor: 4.157

Review 5.  Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia.

Authors:  Gregg W Crabtree; Joseph A Gogos
Journal:  Front Synaptic Neurosci       Date:  2014-11-25

Review 6.  The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.

Authors:  V L Nimgaonkar; K M Prasad; K V Chowdari; E G Severance; R H Yolken
Journal:  Mol Psychiatry       Date:  2017-08-01       Impact factor: 15.992

7.  Association between ErbB4 single nucleotide polymorphisms and susceptibility to schizophrenia: A meta-analysis of case-control studies.

Authors:  Yanguo Feng; Dejun Cheng; Chaofeng Zhang; Yuchun Li; Zhiying Zhang; Juan Wang; Xiao Feng
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.